Light Rain 47°
Tag:

Britain

Police & Fire
'PlugwalkJoe' Admits Unprecedented Twitter Hack That Included Musk, Kardashian, Biden: Feds 'PlugwalkJoe' Admits Unprecedented Twitter Hack That Included Musk, Kardashian, Biden: Feds
'PlugwalkJoe' Admits Unprecedented Twitter Hack That Included Musk, Kardashian, Biden: Feds A 23-year-old British citizen who hacked the Twitter accounts of Joe Biden, Elon Musk, Kim Kardashian and Bill Gates, among others, pleaded guilty in federal court to a host of related charges as part of a deal with the government. Joseph James O'Connor -- also known as "PlugwalkJoe" -- technically faces up to 77 years in prison under federal sentencing guidelines but will likely get somewhere between 10 to 20 years when all is said and done. The Liverpudlian hacker admitted during a plea hearing in federal court in Manhattan on Tuesday, May 9, that he committed one of the largest high-pro…

SHARE

by Jerry DeMarco
News
J&J: Mystery Illness Pauses Largest COVID Vaccine Trial J&J: Mystery Illness Pauses Largest COVID Vaccine Trial
J&J: Mystery Illness Pauses Largest COVID Vaccine Trial A mystery illness suffered by a participant has put the largest COVID-19 vaccine trial on hold, drug maker Johnson & Johnson announced. The New Jersey-based company – which sought 60,000 volunteers mostly over 60 – didn’t describe the illness or identify the patient in any way. “We must respect this participant's privacy,” J&J said in a statement. “We're also learning more about this participant's illness, and it's important to have all the facts before we share additional information.” J&J said it would provide transparent updates throughout the development of the randomized, …

SHARE

by Jerry DeMarco
News
BREAKTHROUGH: Scientists Find Low-Cost Drug Reduces COVID-19 Fatalities BREAKTHROUGH: Scientists Find Low-Cost Drug Reduces COVID-19 Fatalities
Breakthrough: Scientists Find Low-Cost Drug Reduces Covid-19 Fatalities Scientists at the University of Oxford may be on the verge of a COVID-19 breakthrough after discovering a low-cost drug they say is the first to reduce virus-related fatalities for patients on oxygen. After successfully carrying out a 6,000-patient trial, scientists found Dexamethasone -- a well-known, inexpensive steroid -- helped those with severe cases of the virus. One-third of the patients in the trial that were receiving ventilation had a reduced death rate, as did the one-fifth of patients on oxygen when treated with Dexamethasone, the scientists said. Patients who did…

SHARE

by Valerie Musson